Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients

Clinical trial NCT03823989 · COMPLETED

Trial details

NCT number: NCT03823989
Sponsor: Lipomedix Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Solid Tumor Metastatic Disease

Start date: 2019-01-03
Primary completion: 2021-10-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.